MAZE
Financials
- Market Capitalization 1.52 B
- Employee 141
- Founded 2017
- CEO N/A
- Website www.mazetx.com
- Headquarter Delaware, United States
- FIGI BBG00NHJHS27
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1954 |  PVLA Palvella Therapeutics, Inc. - Common Stock | 149.97 USD | -0.24% | +7.11% | +3.79% | +103.07% | 2.16 B USD | ||
| 2021 |  GENB Generate Biomedicines, Inc. - Common Stock | 15.33 USD | -2.79% | -8.53% | +16.93% | +2.20% | 1.97 B USD | ||
| 2742 |  CBIO Crescent Biopharma, Inc. - Common Stock | 17.75 USD | -0.06% | +3.50% | +21.08% | +22.50% | 659.30 M USD | ||
| 2815 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 10.98 USD | -4.69% | -4.69% | +21.33% | -35.60% | 594.73 M USD |
Frequently asked questions about Maze Therapeutics, Inc. Common Stock
What is the Maze Therapeutics, Inc. Common Stock stock price today?
The current price of Maze Therapeutics, Inc. Common Stock (MAZE) is 27.44. Over the past 24 hours, the stock has changed by -4.06%. Follow the MAZE chart for real-time price dynamics.
What is the stock ticker of Maze Therapeutics, Inc. Common Stock?
Maze Therapeutics, Inc. Common Stock trades under the ticker MAZE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Maze Therapeutics, Inc. Common Stock stock going up?
MAZE has changed by -6.25% over the last week, -0.11% over the last month, and -39.06% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Maze Therapeutics, Inc. Common Stock?
Maze Therapeutics, Inc. Common Stock currently has a market capitalization of 1.52 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Maze Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Maze Therapeutics, Inc. Common Stock reported earnings of -0.76 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Maze Therapeutics, Inc. Common Stock revenue for the last quarter?
Maze Therapeutics, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Maze Therapeutics, Inc. Common Stock net income for the last quarter?
Maze Therapeutics, Inc. Common Stock reported net income of -44.73 M for the last quarter. The previous quarter showed -24.21 M, which means net income changed by -84.76%.
How many employees does Maze Therapeutics, Inc. Common Stock have?
As of the latest available data, Maze Therapeutics, Inc. Common Stock has 141 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Maze Therapeutics, Inc. Common Stock stock?
You can buy Maze Therapeutics, Inc. Common Stock (MAZE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Maze Therapeutics, Inc. Common Stock stock?
Investing in Maze Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MAZE chart and related analysis on metatrader.com as part of your research.